Global Health Innovative Technology (GHIT) Fund
Capital Type
Public Private Partnership
Investment Size
Varies by program
Geographic Scope
Japan, Global
Return Model
Non-Dilutive
Stage Focus
Discovery, Translational, Clinical
Modality Focus
Therapeutics, Diagnostics, Vaccines
Overview
Japan-based global health R&D partnership that funds drugs, vaccines, and diagnostics with public-health relevance and can support AMR-relevant infectious disease innovation.
Portfolio and Signals
Especially relevant for infectious disease technologies intended for global health contexts and partnership-based development.
Access and Engagement
Access is through specific GHIT funding calls and cross-border product development collaborations.
Notable AMR Examples / Programs
Infectious-disease product development partnerships
Stay Updated
Stay connected so that you don't miss the latest AMR insights and updates.
